Fletcher-Floras LIS eSuite licensed to HealthTexas

TriMed Staff | | Health Imaging | Practice Management
HealthTexas Medical Group of San Antonio, Texas has signed a license agreement to implement Fletcher-Flora Healthcare Systems’ FFlex eSuite laboratory information system (LIS) services.

According to the Anaheim, Calif.-based Fletcher Flora, its web-based LIS FFlex eSuite is designed to streamline workflow, manage data and deliver clinical test results for a clinical laboratory of any size. The LIS service provider also said the eSuite will allow HealthTexas to access orders, inquiries, quality control and reporting from remote locations to a central database.

HealthTexas Medical Group specializes in internal medicine and family practice and consists of 10 remote clinics throughout Texas.

TriMed Staff

Related Content

Clinicians want AI to show its work
Multidose contrast injectors could increase waste in some radiology departments
Imaging leaders share 7 key considerations for remote scanning programs
Policies and regulations shaping radiology in 2025
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.